Clinical Trial Update: Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069

View source ↗

Summary

Update on the HOPEFUL III rheumatoid arthritis study, a follow-up survey of Study P12-069, which has completed and posted its results. The document summarizes t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-03-11